Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Senior Manager
Telephone: 412-578-9193 or 412-624-3212

Common Treatment For Endometriosis Is Linked To Ovarian Cancer, Say University Of Pittsburgh Researchers

PITTSBURGH, March 18, 2002 — A commonly prescribed medication for treating endometriosis appears to elevate the risk of ovarian cancer, according to findings presented by a University of Pittsburgh Graduate School of Public Health (GSPH) researcher at the 33rd annual meeting of the Society of Gynecologic Oncologists in Miami.

In the study, women taking danazol, a synthetic version of the male hormone androgen, were nearly three times more likely to develop ovarian cancer than were women taking leuprolide, an anti-androgenic, gonadotropin-releasing hormone agonist. Both drugs are used to treat endometriosis, a painful disease in which pieces of uterine tissue migrate to other parts of the body.

"Our previous studies have found that women with endometriosis are already at a 50-percent increased risk for ovarian cancer, and treating them with danazol appears to further increase their risk. This new result, even though it is preliminary, may factor into the equation when clinicians and their patients with endometriosis are deciding on the best treatment," said presenter Roberta B. Ness, M.D., M.P.H., associate professor of epidemiology at the GSPH and director of the school's Epidemiology of Women's Health Program.

The study analyzed pooled data from two case-control studies that examined the relationships among endometriosis, endometriosis treatments and ovarian cancer. Among women with endometriosis, 17 took danazol and 15 took leuprolide. Analysis showed that the study participants who took danazol were 2.7 times more likely to have ovarian cancer than were other women with endometriosis who did not take danazol. Women taking leuprolide had no significant elevation in risk.

"While the number of women studied is small, the results are telling, and they warrant further studies on a larger scale," said the study's principal investigator, Carrie Cottreau, Ph.D., assistant professor of obstetrics and gynecology, University of Pittsburgh School of Medicine .

Additional research studies are planned at the University of Pittsburgh to further investigate the link between androgens and ovarian cancer.

Earlier this year, Dr. Ness and colleagues published results of a study showing that there is no association between fertility drugs and ovarian cancer. However, the study showed that the risk of ovarian cancer is 50 percent higher in women with endometriosis than it is for women without endometriosis.

Established in 1948, the University of Pittsburgh Graduate School of Public Health is considered a leader in the field of women's health research and is world-renowned for contributions that have influenced public health practices and medical care for millions of people. It is the only fully accredited school of public health in the Commonwealth of Pennsylvania and is one of the top-ranked schools of public health in the United States. It is one of eight schools across the country to be designated a Public Health Training Center by the U.S. Department of Health and Human Services.

For more information, access the school’s website at http://www.publichealth.pitt.edu/.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com